Powered by: Motilal Oswal
2025-12-21 02:28:23 pm | Source: PR Agency
Tata Chemicals arm to acquire Novabay for €25 mn, boosts premium sodium bicarb portfolio
Tata Chemicals arm to acquire Novabay for €25 mn, boosts premium sodium bicarb portfolio

Tata Chemicals Limited (TCL)todayannounced that Tata Chemicals International Pte. Limited (TCIPL) a 100% subsidiary of TCL, has signed a Share Purchase Agreement (SPA) to acquire 100% equity shares of Novabay Pte. Limited (Novabay) manufacturer of premium grade sodium bicarbonate.

Commenting on the acquisition, Managing Director CEO, TCL, said, Novabay’s focus on premium-grade sodium bicarbonate aligns seamlessly with TCL’s strategy to expand its presence in high-value, non-cyclical product segments. This acquisition strengthens TCL’s capabilities in specialty bicarb market and enhances our ability to serve premium customer requirements.

Novabay is among the largest premium sodium bicarbonate producers in the Asia-Pacific region (excluding China), supplying high-value grades for pharmaceutical, personal care, and food applications. The company holds key cGMP, API, and related certifications, supported by a fully automated facility. With a current capacity of approximately 60,000 tons and potential to expand to 100,000 tons, Novabay is well-positioned for growth.

The premium-grade sodium bicarbonate market benefits from steady demand in healthcare, personal care, and food sectors. Rising haemodialysis needs, improved access to medical care, and growing consumption in emerging markets drive this demand. We believe this strategic acquisition will accelerate TCL’s long-term growth and value creation.”

 

Above views are of the author and not of the website kindly read disclaimer

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here